Skip to main content

ACR Convergence Preview (11.10.2023)

Dr. Jack Cush reviews this past week's news on and suggests a learning plan for those wanting to consume the upcoming ACR Convergence 2023 meeting. 

  1. 2023 Medscaped Female Compensation Survey asked What percentage would again chose their specialty ? Top 5 specialties rechosen: Cardiology: 82% & Dermatology: 82% Psychiatry: 81% Allergy and immunology: 80% Neurology: 79% Rheumatology: 78%

  2. Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX superior to AZA in preventing major relapses at 84mos (HR 0.38), but tailored-RTX assoc w/ incr risk of major relapse (HR 2.92)

  3. Biologics, #RA and Risk of skin CA (NMSC) is complex. - RA alone is a risk for NMSC 49K study of ABA & NMSC ; - In RCTs, risk same w/ ABA & PBO - Registries & Claims data: equal w/ ABA, csDMARDs. b/tsDMARDs - Pooled obs data shows slight ABA risk

  4. UK biobank population study shows a bidirectional assoc. betw RA & COPD (each @ incr risk for the other). In non-COPD pts, RA increased risk of COPD (HR=1.65) & in non-RA pts, COPD had a higher risk of future RA (HR=1.67). Both mediated by inflammation

  5. Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions.

  6. Good Treatment review of biologics (IL-1, IL-6) in systemic JIA (Stills) including complications of #MAS and lung disease; also info on horizon therapies like JAK inhibitors and IL-18 targeting and novel biomarkers (calgranulins, IL-18 and CXCL9)

  7. LANCET: Efgartigimod (neonatal Fc receptor mAb) shown effective in chronic #ITP. RCT, 205 pts with refractory ITP (Plt <30K for ~10.6 yrs) Rx w/ EFGR vs PBO. @24 wks EFGR incr Plt >50k in 22% vs. 6%). A larger RCT in progress

  8. Marijuana use is on the rise, including older adults. Data presented at 2023 AHA (cardiology) meeting suggests that marijuana user have higher risk of MI & CVA; & daily marijuana users were 34% more likely to develop heart failure (in hospitalized adults)

  9. Retrospective study(2016-2019) of referred newly, suspected (#RA) pts found no value in initial Xrays. Only 32/724 patients (4.4%) had RA like erosions, with Erosions leading to a Dx in only 2 pts (0.3%) & changed prognostic classification in 3 pts (0.4%)

  10. Follow RheumNow's coverage of ACR 2023, specifically:

    • Twice Daily emails beginning Sunday 11/12/23

    • Daily Recap Panel discussion starting Sunday 11/12 at 6pm PST (9pm EST) - these will be live-streamed on our website, and our social media pages - YouTube, Twitter, LinkedIn and Facebook

    • 50-60 day written articles from the RheumNow faculty

    • Daily Podcasts from the meeting

    • Sign up for Topic report emails (on the RheumNow registration page) - these will be sent to you every Monday

    • Next Friday - Rheumatology Roundup - an ACR23 review from Drs. Artie Kavanaugh and Jack Cush


If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

The author has received compensation as an advisor or consultant on this subject